SCHEMBL9429101

SCHEMBL9429101

CC=CC(=O)N(c1ccc(-c2cccc(Cl)c2)s1)C1CCNC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.42
SLC6A2 P23975 8/20 0.41
SLC6A4 P31645 8/20 0.41
SLC6A3 Q01959 4/20 0.41
CHEK1 O14757 5/20 0.38
CDK2AP1 O14519 1/20 0.38
MBTPS1 Q14703 1/20 0.37
MCHR1 Q99705 1/20 0.37
KCNH2 Q12809 2/20 0.37
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
TACR1 P25103 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM3 P20309 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9428834 0.91 SLC6A4 (0.39) CHRM1SLC6A2SLC6A4SLC6A3MBTPS1
SCHEMBL9429984 0.90 SLC6A4 (0.39) SLC6A2SLC6A4SLC6A3CHEK1CDK2AP1
SCHEMBL9428841 0.89 HSD17B1 (0.38) SLC6A2SLC6A4SLC6A3KCNH2HSD17B1
SCHEMBL9429149 0.88 SLC6A4 (0.36) CHRM1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9429162 0.87 HDAC6 (0.41) SLC6A2SLC6A4SLC6A3CHEK1MCHR1
SCHEMBL9429798 0.85 CDK2AP1 (0.35) SLC6A2SLC6A4SLC6A3CHEK1CDK2AP1
SCHEMBL9428532 0.84 MCHR1 (0.40) SLC6A2SLC6A4SLC6A3CHEK1CDK2AP1
SCHEMBL9429749 0.84 EP300 (0.35) SLC6A2SLC6A4SLC6A3MCHR1KCNH2
SCHEMBL9429795 0.84 SLC6A4 (0.34) SLC6A2SLC6A4SLC6A3KCNH2TACR1
SCHEMBL9429644 0.82 APP (0.37) CHEK1MCHR1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
EP-0440503-A1 4-Isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-08-07 EP disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed